Zentek Limited (ZTEK) - Multiplikator forward rega marang pendapatan

zentek.com (ZTEK) - logo korporat

The forward P/S ratio reflects the expected sales dynamics of graphene materials and security systems for plants, where the value 779.70 serves as the baseline indicator. Business resilience is driven by the integration of nano-coatings into filters and masks, which mitigates industry risks. The high authority of Zentek Ltd. (ZTEK) as the developer of ZenGUARD confirms its technological superiority and growing trust among medical professionals.

ZTEK zentek.com: Multiplikator forward rega marang pendapatan ing interval 28.04.2023 - 12.09.2026

Zentek - rincian analitis lan metrik utama (ZTEK)

- rega pasar lan target rega analis:
- indikator kapitalisasi pasar:
Analisis umum perusahaan:ZTEK (Zentek Corp)
Produk asli zentek.com

Identifying a fundamental floor for Zentek Ltd. (ZTEK) requires analyzing the ratio of current market capitalization to projected revenue from the expansion of nano-coatings in medicine. The expected P/S ratio reflects the market valuation of future cash flows, allowing investors to determine the extent to which the share price is outpacing the scaling of production and the execution of B2B contracts, which is critical for assessing the reliability of this high-tech asset.

Analisis perusahaan pesaing

Rasio rega marang prakiraan pendapatan Intuitive Surgical Inc ISRG|Multiplikator Forward P/S Danaher Corporation Inc. DHR|BDX - Rasio rega marang prakiraan pendapatan|STERIS plc (STE) - Multiplikator forward rega marang pendapatan|WST: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Baxter International Inc. (BAX)|MASI (masimo.com) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Stevanato Group Corp STVN|Multiplikator forward rega marang pendapatan TFX (Teleflex Inc)|Merit Medical - Kapitalisasi marang prakiraan pendapatan|Envista Holdings - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake ICUI (ICU Medical Inc)|XRAY - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake LeMaitre Corp LMAT|ATRC: Multiplikator Forward P/S|STAA - Rasio kapitalisasi marang dodolan sing dikarepake|NAGE (Chromadex Corp) - Multiplikator Forward P/S|ZimVie Inc (ZIMV) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S ANGO|CERS (Cerus Corporation) - Rega forward marang dodolan|Multiplikator Forward P/S TKNO (Alpha Teknova, Inc.)|Monogram Technologies (MGRM) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|STSS - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake InfuSystem INFU|Utah Med (UTMD) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan KORU Medical Systems, Inc.|Multiplikator forward rega marang pendapatan NYXH|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Microbot Medical MBOT|Multiplikator forward rega marang pendapatan PDEX (Pro-Dex)|Rasio kapitalisasi marang dodolan sing dikarepake Elutia Inc|Multiplikator Forward P/S MLSS (milestonescientific.com)|NXGL: Kapitalisasi marang prakiraan pendapatan|Retractable Tech - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Harvard Bioscience Inc. HBIO|FEMY: Multiplikator Forward P/S|MeihuaMed - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Predictive Oncology Inc|callanjmb.com (CJMB) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Atrion Corporation (ATRI)|Rasio kapitalisasi marang dodolan sing dikarepake neurometrix.com